Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free IRON Stock Alerts

Disc Medicine (IRON) Earnings Date, Estimates & Call Transcripts

Disc Medicine logo
$77.44 0.00 (0.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$77.51 +0.07 (+0.09%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Disc Medicine Earnings Summary

Disc Medicine announced Q2 2026 earnings on July 30, 2026, reporting an EPS of -$1.54, which beat analysts' consensus estimates of -$1.71 by $0.17. With a trailing EPS of -$6.58, Disc Medicine's earnings are expected to decrease next year, from ($6.61) to ($7.13) per share.

Latest Q2
Earnings Date
Jul. 30Estimated
Consensus EPS
(Jul. 30)
-$1.71
Actual EPS
(Jul. 30)
-$1.54 Beat By $0.17

Q2 2026 Earnings Resources

Powered by Quartr
Get Disc Medicine Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Disc Medicine and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IRON Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Disc Medicine Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.69-$1.63-$1.66
Q2 20262-$1.67-$1.64-$1.66
Q3 20262-$1.71-$1.56-$1.64
Q4 20262-$1.74-$1.44-$1.59

Disc Medicine Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026-$1.71-$1.54+$0.17-$1.54$1.00M-
5/5/2026Q1 2026-$1.6227-$1.65 -$0.0273-$1.65$0.44M-
2/26/2026Q4 2025-$1.69-$1.62+$0.07-$1.62$0.15M-$19.88M
11/6/2025Q3 2025-$1.48-$1.77 -$0.29-$1.77--
8/7/2025Q2 2025-$1.17-$1.58 -$0.41-$1.58--
5/7/2025Q1 2025-$0.99-$1.02 -$0.03-$1.02--
2/27/2025Q4 2024-$1.06-$0.98+$0.08-$0.98--
11/12/2024Q3 2024-$1.04-$0.89+$0.15-$0.89--

Disc Medicine Earnings - Frequently Asked Questions

Disc Medicine (NASDAQ:IRON) last announced its quarterly earning data on Thursday, July 30, 2026. Learn more on IRON's earnings history.

In the previous quarter, Disc Medicine (NASDAQ:IRON) reported ($1.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.71) by $0.17. Learn more on analysts' earnings estimate vs. IRON's actual earnings.

Disc Medicine (NASDAQ:IRON) has a recorded net income of -$212.18 million. IRON has generated -$6.58 earnings per share over the last four quarters.

Disc Medicine's earnings are expected to decrease from ($6.61) per share to ($7.13) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:IRON is sourced from Fiscal.ai, with the most recent quarter reported on 7/30/2026. New results are added as companies report their earnings.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. d...
Priority Gold | Sponsoredtc pixel
China is not hedging. It's escaping.
China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...
Behind the Markets | Sponsoredtc pixel
This Junior Silver Explorer Is Closing In on Its Biggest Catalyst
A past-producing Nevada silver project holds a historical 36 million ounce silver-equivalent resource, plus mo...
Wall Street Logic | Sponsoredtc pixel
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for P...
The Tomorrow Investor | Sponsoredtc pixel